163 related articles for article (PubMed ID: 9213025)
1. Time course of smooth muscle cell proliferation after local drug delivery of low-molecular-weight heparin using a porous balloon catheter.
Oberhoff M; Herdeg C; Baumbach A; Shamet K; Kranzhöfer A; Weingärtner O; Rübsamen K; Kluge M; Karsch KR
Cathet Cardiovasc Diagn; 1997 Jul; 41(3):268-74. PubMed ID: 9213025
[TBL] [Abstract][Full Text] [Related]
2. Local and systemic delivery of low molecular weight heparin stimulates the reendothelialization after balloon angioplasty.
Oberhoff M; Novak S; Herdeg C; Baumbach A; Kranzhöfer A; Bohnet A; Horch B; Hanke H; Haase KK; Karsch KR
Cardiovasc Res; 1998 Jun; 38(3):751-62. PubMed ID: 9747444
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of low-molecular-weight heparin delivery with the Dispatch catheter following balloon angioplasty in the rabbit iliac artery.
Baumbach A; Oberhoff M; Bohnet A; Miljak T; Herdeg C; Horch B; Blessing E; Kunert W; Haase KK; Karsch KR
Cathet Cardiovasc Diagn; 1997 Jul; 41(3):303-7. PubMed ID: 9213029
[TBL] [Abstract][Full Text] [Related]
4. Local drug delivery with porous balloons in the rabbit: assessment of vascular injury for an improvement of application parameters.
Herdeg C; Oberhoff M; Baumbach A; Haase KK; Horch B; Kranzhoefer A; Karsch KR
Cathet Cardiovasc Diagn; 1997 Jul; 41(3):308-14. PubMed ID: 9213030
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of smooth muscle cell proliferation after local drug delivery of the antimitotic drug paclitaxel using a porous balloon catheter.
Oberhoff M; Kunert W; Herdeg C; Küttner A; Kranzhöfer A; Horch B; Baumbach A; Karsch KR
Basic Res Cardiol; 2001; 96(3):275-82. PubMed ID: 11403421
[TBL] [Abstract][Full Text] [Related]
6. Localized delivery of heparin to angioplasty sites with iontophoresis.
Mitchel JF; Azrin MA; Fram DB; Bow LM; McKay RG
Cathet Cardiovasc Diagn; 1997 Jul; 41(3):315-23. PubMed ID: 9213031
[TBL] [Abstract][Full Text] [Related]
7. Local urokinase delivery with the Channel balloon: device safety, pharmacokinetics of intracoronary drug delivery, and efficacy of thrombolysis.
Mitchel JF; Barry JJ; Bow L; Alberghini TA; Abbas SA; McKay RG
Cathet Cardiovasc Diagn; 1997 Jul; 41(3):254-60. PubMed ID: 9213023
[TBL] [Abstract][Full Text] [Related]
8. Sustained local drug delivery to the arterial wall via biodegradable microspheres.
Dev V; Eigler N; Fishbein MC; Tian Y; Hickey A; Rechavia E; Forrester JS; Litvack F
Cathet Cardiovasc Diagn; 1997 Jul; 41(3):324-32. PubMed ID: 9213032
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cellular proliferation after experimental balloon angioplasty by low-molecular-weight heparin.
Hanke H; Oberhoff M; Hanke S; Hassenstein S; Kamenz J; Schmid KM; Betz E; Karsch KR
Circulation; 1992 Apr; 85(4):1548-56. PubMed ID: 1313343
[TBL] [Abstract][Full Text] [Related]
10. Porous balloon catheters for local delivery: assessment of vascular damage in a rabbit iliac angioplasty model.
Plante S; Dupuis G; Mongeau CJ; Durand P
J Am Coll Cardiol; 1994 Sep; 24(3):820-4. PubMed ID: 8077558
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and efficacy of locally delivered enoxaparin via the Channeled Balloon catheter on smooth muscle cell proliferation following balloon injury in rabbits.
Hong MK; Wong SC; Barry JJ; Bramwell O; Tjurmin A; Leon MB
Cathet Cardiovasc Diagn; 1997 Jul; 41(3):241-5. PubMed ID: 9213021
[TBL] [Abstract][Full Text] [Related]
12. Porous balloon delivery of low molecular weight heparin in the dog coronary artery.
Baumbach A; Oberhoff M; Rübsamen K; Jochims K; Herdeg C; Kranzhöfer A; Safer A; Karsch KR
Eur Heart J; 1996 Oct; 17(10):1538-45. PubMed ID: 8909911
[TBL] [Abstract][Full Text] [Related]
13. Intramural drug delivery by direct injection within the arterial wall: first clinical experience with a novel intracoronary delivery-infiltrator system.
Pavlides GS; Barath P; Maginas A; Vasilikos V; Cokkinos DV; O'Neill WW
Cathet Cardiovasc Diagn; 1997 Jul; 41(3):287-92. PubMed ID: 9213027
[TBL] [Abstract][Full Text] [Related]
14. Local alcohol delivery may reduce phenotype conversion of smooth muscle cells and neointimal formation in rabbit iliac arteries after balloon injury.
Liu MW; Lin SJ; Chen YL
Atherosclerosis; 1996 Dec; 127(2):221-7. PubMed ID: 9125312
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of macrophages in the arterial vessel wall following experimental balloon angioplasty.
Hanke H; Hassenstein S; Ulmer A; Kamenz J; Oberhoff M; Haase KK; Baumbach A; Gown AM; Karsch KR
Eur Heart J; 1994 May; 15(5):691-8. PubMed ID: 8056012
[TBL] [Abstract][Full Text] [Related]
16. Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries. The role of heparin-sensitive and -insensitive pathways in the stimulation of smooth muscle cell migration and proliferation.
Geary RL; Koyama N; Wang TW; Vergel S; Clowes AW
Circulation; 1995 Jun; 91(12):2972-81. PubMed ID: 7796508
[TBL] [Abstract][Full Text] [Related]
17. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.
Francis DJ; Parish CR; McGarry M; Santiago FS; Lowe HC; Brown KJ; Bingley JA; Hayward IP; Cowden WB; Campbell JH; Campbell GR; Chesterman CN; Khachigian LM
Circ Res; 2003 May; 92(8):e70-7. PubMed ID: 12690039
[TBL] [Abstract][Full Text] [Related]
18. Local delivery of heparin to balloon angioplasty sites with a new angiotherapy catheter: pharmacokinetics and effect on platelet deposition in the porcine model.
Fram DB; Mitchel JF; Azrin MA; Chow MS; Waters DD; McKay RG
Cathet Cardiovasc Diagn; 1997 Jul; 41(3):275-86. PubMed ID: 9213026
[TBL] [Abstract][Full Text] [Related]
19. Intramural methotrexate therapy for the prevention of neointimal thickening after balloon angioplasty.
Muller DW; Topol EJ; Abrams GD; Gallagher KP; Ellis SG
J Am Coll Cardiol; 1992 Aug; 20(2):460-6. PubMed ID: 1386089
[TBL] [Abstract][Full Text] [Related]
20. Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth.
Igarashi M; Takeda Y; Mori S; Ishibashi N; Komatsu E; Takahashi K; Fuse T; Yamamura M; Kubo K; Sugiyama Y; Saito Y
Br J Pharmacol; 1997 Mar; 120(6):1172-8. PubMed ID: 9134232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
